multiplex diagnostics
A handful of firms have announced they are developing at-home combo kits that can detect and differentiate COVID-19, flu A, and B on current testing platforms.
Luminex Obtains CE Marking for MDx Panel to Detect Flu A/B, RSV, COVID-19
Results are generated in a single workflow from a patient sample, which enables rapid detection for the differential diagnosis of a single pathogen.
The firm expects to establish a US-based development and manufacturing footprint for its multiplex PCR assay kits.
The firm submitted a low-cost RT-LAMP device and COVID test to the FDA for Emergency Use Authorization this week.
Prolight Diagnostics to Acquire UK Point-of-Care Firm Psyros Diagnostics for $7.1M
Psyros said its single-molecule counting technology would enable multiplexing and the measurement of biomarkers at femtomolar concentrations in 10 minutes or less.
Feb 27, 2020
Feb 11, 2020
Jan 30, 2020
Dec 18, 2019
Dec 17, 2019
ChromaCode Raises $28M in Series C Financing
Dec 12, 2019